Ginger.io and the Collaborative Chronic Care Network (C3N) are recruiting Crohn’s disease and ulcerative colitis patients for a clinical trial of the Ginger.io mobile application.
The goal is to help doctors capture the experiences of adolescents managing their Irritable Bowel Disease (IBD) and helps patients predict flares so they might take steps to avery future symptoms.
Interested participants must meet the following inclusion criteria to be eligible to participate:
- Patient age 13 to 18 years
- Diagnosis of Crohn’s disease or ulcerative colitis
- Symptoms in the past 4 weeks
If you agree to participate and qualify for this study, the following will happen:
- You will be asked to download and install an application onto your smartphone for the purposes of the study.
- The application will ask you periodically to complete surveys. At the end of the study period, you can remove/uninstall the application from your phone.
- Participate in an interview about your experience. The interview will take about 1 hour and can be conducted over the phone, video conference, or web survey.
See the video below featuring Dr. Michael Seid, principal investigator of the ginger.io study. It is called Passive Tracking of Patient Outcomes and has Dr. Michael Seid of Cincinnati Children’s and Anmol Madan of Ginger.IO.